Format

Send to

Choose Destination
See comment in PubMed Commons below
Bioorg Med Chem Lett. 2007 Apr 15;17(8):2278-80. Epub 2007 Jan 27.

Minor groove binder antibody conjugates employing a water soluble beta-glucuronide linker.

Author information

1
Seattle Genetics Inc., 21823 30th Drive S.E., Bothell, WA 98021, USA. sjeffrey@seagen.com

Abstract

The minor groove binder beta-glucuronide drug-linker 3 was constructed from amino CBI 1 and determined to be a substrate for Escherichia coli beta-glucuronidase (EC 3.2.1.31), resulting in facile drug release. Compound 3 was conjugated to mAbs cAC10 (anti-CD30) and h1F6 (anti-CD70) to give antibody-drug conjugates (ADCs) with potencies comparable to that of free drug 1. The ADCs were largely monomeric at intermediate loading levels (4-5drug/mAb), in contrast to highly aggregated p-aminobenzylcarbamate dipeptide-based ADCs of 1 previously reported. Significant levels of immunologic specificity were observed with cAC10-3 by comparing antigen positive versus negative cell lines and binding versus non-binding control ADCs. The water soluble beta-glucuronide linker is stable in plasma and effectively delivers drugs to target cells leading to potent cytotoxic activities.

PMID:
17293111
DOI:
10.1016/j.bmcl.2007.01.071
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center